Related Experiment Video
Updated: Dec 6, 2025

Tissue-specific miRNA Expression Profiling in Mouse Heart Sections Using In Situ Hybridization
Published on: September 15, 2018
Integrated analysis of mRNA and microRNA expression profiles reveals differential transcriptome signature in
Xiuli Shao1, Xiaolin Zhang1, Lei Yang2
1Department of Pharmaceutical Toxicology, School of Pharmacy, China Medical University, Shenyang, China.
Insights
This study identifies miR-542-3p and its target CILP as key regulators in heart failure, potentially offering new diagnostic and therapeutic targets for ischemic and dilated cardiomyopathy.
Area of Science:
- Cardiovascular Biology
- Molecular Medicine
- Genomics
Background:
- Cardiac remodelling is a hallmark of heart failure (HF), impacting conditions like ischemic cardiomyopathy (ICM) and dilated cardiomyopathy (DCM).
- MicroRNAs (miRNAs) and messenger RNAs (mRNAs) are implicated as diagnostic and therapeutic targets in HF, but their joint regulatory mechanisms remain poorly understood.
- Understanding these molecular interactions is crucial for developing effective treatments for HF.
Purpose of the Study:
- To investigate the mechanisms of microRNA-mRNA joint regulation in heart failure.
- To identify key genes and pathways involved in ICM and DCM-induced HF.
- To discover novel diagnostic and therapeutic targets for HF.
Main Methods:
- Analysis of three gene expression profiles from patients with and without HF.
- Weighted Gene Co-Expression Network Analysis (WGCNA) to identify key genes in ICM and DCM.
- MicroRNA-mRNA interaction network analysis and pathway analysis.
Main Results:
- Shared differentially expressed miRNAs and mRNAs with significant biological functions were identified.
- The study pinpointed miR-542-3p and its target gene CILP as potentially involved in the TGF-β signaling pathway in ICM-induced HF.
- A novel mechanism involving miR-542-3p-CILP in the TGF-β signaling pathway was proposed for mediating ICM-induced HF.
Conclusions:
- The miR-542-3p-CILP interaction within the TGF-β signaling pathway represents a potential novel mechanism in ICM-induced HF.
- This study provides novel molecular targets for the diagnosis and therapeutic treatment of ICM- and DCM-induced HF.
- Further research into these identified targets could lead to improved management of heart failure.
Abstract:
Cardiac remodelling is widely accepted as a common characteristic for many heart diseases, especially in heart failure (HF). Ischaemic cardiomyopathy (ICM) and dilated cardiomyopathy (DCM) are associated with cardiac remodelling. Both mRNA and microRNA are potential diagnostic markers and therapeutic targets of cardiac remodelling in HF. However, the mechanisms of microRNA-mRNA joint regulation in HF are still unclear. In this study, 3 gene expression profiles from patients with and without HF were analysed to harvest shared differentially expressed genes (microRNA and mRNA) with significant major biological function. Moreover, key genes highly related to ICM and DCM-induced HF were screened out through a Weighted Genes Co-Expression Network Analysis (WGCNA). Based on microRNA-mRNA analysis, several microRNAs and target genes were identified. Combined with pathway analysis, we found that miR-542-3p and its target gene CILP were likely involved in the regulation of TGF-β signalling pathway in ICM induced HF. Collectively, the microRNA-mRNA interaction network analysis revealed that miR-542-3p-CILP as mediator of TGF-β signalling pathway might be a new mechanism to mediate ICM induced HF. This study provides certain novel targets for diagnosis and therapeutic treatment of ICM- and DCM-induced HF.
More Related Videos
Related Concept Videos
MicroRNAs
MicroRNAs

